Simpler kinetics compared to other known tracers
Increased safety for patients and reduced staff risk
Three double exams (stress and rest) per hour, eight hours or more per day!
MedTrace (Denmark) has developed several novel safety features, which combined will revolutionize blood flow imaging in PET. Our solution automates bedside production and infusion of radioactive water in the PET scanner suite – just in time for medical demands. The solution consists of a remote operated unit producing the radioactive water and two disposable kits, including a daily kit for production, and a patient kit for infusion.
The MedTrace system is considered a platform technology. Our first priority is the heart study application, subsequently brain and tumor vascularization and diabetes studies. Micro-vascular applications will be considered as well.
“The flow of water through the tissues is essentially what makes life possible. All diseases affect the flow of water one way or another. This opens up powerful opportunities of diagnosis using 15O-water and PET”
Professor Jens Soerensen MD PhD, PET Centre, Uppsala University Hospital, Sweden
REVOLUTIONIZE BLOOD FLOW IMAGING IN PET
Today’s myocardie perfusion exams use TC99m, Rb-82 and NH3 to treat patients. The globally recognized gold standard tracer for blood flow analysis is O-15 H2O (radioactive water), which is used in most clinical studies as the benchmark. The short half-life of radioactive water as well as lack of regulatory approved equipment has limited its use in clinical practice so far. MedTrace is a Danish life science startup that has developed a fully automated water system with unique and patent- pending safety features. Connected to an in-house cyclotron, the MedTrace water system will efficiently produce radioactive water and inject it into the patient in the PET scanner.
THIS WILL ALLOW
Access to gold standard tracer (O-15 H2O) for routine blood flow exams
Faster patient turnaround (2-3 double-tests/hour)
Absolute safety for patients and staff
In-house production of the tracer- no 3rd party logistics dependencies
Blood flow to selected brain domains, incl. quantification of apoplexy, alzheimer, dementia, schizophrenia etc.
Myocardial perfusion – the gold standard.
|Clinical Physiology |
General organ specific blood perfusion, for organ functionality assessment.
Ischemic muscle, collateral blood supply.
“The availability of a reliable CE approved system for bed-side production of O-15 water could change O-15 water PET from an exotic research tool to a clinical workhorse”
Physicist Lars Poulsen Tolbod, Aarhus University Hospital, Denmark
Rune Wiik Kristensen
Pernille R. Vergmann
Project Coordinator – Design & Engineering
Student Assistant - Scientific Affairs
OUR BOARD OF DIRECTORS
Bjarne Henning Jensen
Chairman of the board, MedTrace A/SBjarne holds a PhD in Chemical Engineering as well as a business degree in communication. Bjarne has both venture and operational/strategic industry background. He serves as CEO of SydDansk Teknologisk Innovation who is one of MedTrace’s main investors.
Vice-chairman of the board, MedTrace A/SMads holds an engineering degree combined with a business degree in accounting and finance. Bjarne has a thorough industrial background combined with investor experience. Mads serves as Partner in the business accelerator Accelerace and as Investment Director in WelfareTech Invest who is one of MedTrace’s investors.
Bernt Skou Jensen
Member of the board, MedTrace A/SBernt holds a master degree in engineering combined with a MBA. Bernt has global exposure and a solid background in manufacturing. Bernt is now self-employed as management consultant in U-Turn Company.
With a background in regulatory affairs and quality management in life sciences, Dorte guides MedTrace through the world of compliance.
Henrik is a MD and background and an experienced entrepreneur in the medical device field and provides general feedback on our business plan as well as company development.
Henrik’s background as industrial designer and his experience in the medical device field serves as great foundation for discussions on product and customer development.
Henrik has for the past two decades worked in R&D leadership functions of large Danish medical device companies. This experience serves as good inspiration for MedTrace’s technological development pathway.
GRANTS AND AWARDS
“We are confident that the introduction of the MedTrace solution will be a paradigm shift in diagnostic imaging impacting most known disease areas.”